{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:07:10Z","timestamp":1790842030077,"version":"4.1.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T00:00:00Z","timestamp":1574380800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013780","name":"Limb Girdle Muscular Dystrophy 2i Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50AR065139"],"award-info":[{"award-number":["P50AR065139"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R44CA221539"],"award-info":[{"award-number":["R44CA221539"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 GM007270"],"award-info":[{"award-number":["T32 GM007270"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.omtm.2019.11.015","type":"journal-article","created":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T19:52:58Z","timestamp":1574797978000},"page":"122-132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Micro-dystrophin Gene Therapy Partially Enhances Exercise Capacity in Older Adult mdx Mice"],"prefix":"10.1016","volume":"17","author":[{"given":"Buel D.","family":"Rodgers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yemeserach","family":"Bishaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denali","family":"Kagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian N.","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph W.","family":"Maricelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2019.11.015_bib1","doi-asserted-by":"crossref","first-page":"15457","DOI":"10.1074\/jbc.R200031200","article-title":"Dystrophin-glycoprotein complex: post-translational processing and dystroglycan function","volume":"278","author":"Michele","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtm.2019.11.015_bib2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1101\/sqb.2002.67.389","article-title":"The sarcoglycan complex in striated and vascular smooth muscle","volume":"67","author":"Wheeler","year":"2002","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"10.1016\/j.omtm.2019.11.015_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/humu.1380040102","article-title":"Searching for the 1 in 2,400,000: a review of dystrophin gene point mutations","volume":"4","author":"Roberts","year":"1994","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.omtm.2019.11.015_bib4","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1542\/peds.2014-2044","article-title":"Prevalence of Duchenne and Becker muscular dystrophies in the United States","volume":"135","author":"Romitti","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.omtm.2019.11.015_bib5","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1016\/j.ymthe.2018.07.011","article-title":"Systemic AAV micro-dystrophin gene therapy for Duchenne muscular dystrophy","volume":"26","author":"Duan","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2019.11.015_bib6","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.ymthe.2017.02.019","article-title":"Progress toward gene therapy for Duchenne muscular dystrophy","volume":"25","author":"Chamberlain","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2019.11.015_bib7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/mt.2009.258","article-title":"Characterization of genome integrity for oversized recombinant AAV vector","volume":"18","author":"Dong","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2019.11.015_bib8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/mt.2009.256","article-title":"Evidence for the failure of adeno-associated virus serotype 5 to package a viral genome > or\u00a0= 8.2 kb","volume":"18","author":"Lai","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2019.11.015_bib9","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/j.2040-4603.2015.tb00638.x","article-title":"The dystrophin complex: structure, function, and implications for therapy","volume":"5","author":"Gao","year":"2015","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.omtm.2019.11.015_bib10","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.bbadis.2006.05.010","article-title":"Dystrophin, its interactions with other proteins, and implications for muscular dystrophy","volume":"1772","author":"Ervasti","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.omtm.2019.11.015_bib11","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ymthe.2019.01.002","article-title":"Development of novel micro-dystrophins with enhanced functionality","volume":"27","author":"Ramos","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2019.11.015_bib12","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1172\/JCI36612","article-title":"Dystrophins carrying spectrin-like repeats 16 and 17 anchor nNOS to the sarcolemma and enhance exercise performance in a mouse model of muscular dystrophy","volume":"119","author":"Lai","year":"2009","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2019.11.015_bib13","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1073\/pnas.1211431109","article-title":"\u03b12 and \u03b13 helices of dystrophin R16 and R17 frame a microdomain in the \u03b11 helix of dystrophin R17 for neuronal NOS binding","volume":"110","author":"Lai","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2019.11.015_bib14","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1093\/hmg\/ddy197","article-title":"Syntrophin binds directly to multiple spectrin-like repeats in dystrophin and mediates binding of nNOS to repeats 16-17","volume":"27","author":"Adams","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2019.11.015_bib15","doi-asserted-by":"crossref","first-page":"e1000958","DOI":"10.1371\/journal.pgen.1000958","article-title":"The polyproline site in hinge 2 influences the functional capacity of truncated dystrophins","volume":"6","author":"Banks","year":"2010","journal-title":"PLoS Genet."},{"key":"10.1016\/j.omtm.2019.11.015_bib16","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1093\/hmg\/ddn301","article-title":"Molecular and cellular adaptations to chronic myotendinous strain injury in mdx mice expressing a truncated dystrophin","volume":"17","author":"Banks","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2019.11.015_bib17","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1124\/jpet.102.041343","article-title":"Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1","volume":"304","author":"De Luca","year":"2003","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.omtm.2019.11.015_bib18","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/ar.1092420109","article-title":"Phenotype of dystrophinopathy in old mdx mice","volume":"242","author":"Lefaucheur","year":"1995","journal-title":"Anat. Rec."},{"key":"10.1016\/j.omtm.2019.11.015_bib19","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1469-7793.2001.00591.x","article-title":"Force and power output of fast and slow skeletal muscles from mdx mice 6-28\u00a0months old","volume":"535","author":"Lynch","year":"2001","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.omtm.2019.11.015_bib20","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/mus.24184","article-title":"A novel protocol for assessing exercise performance and dystropathophysiology in the mdx mouse","volume":"50","author":"Rocco","year":"2014","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.omtm.2019.11.015_bib21","doi-asserted-by":"crossref","first-page":"e28569","DOI":"10.1371\/journal.pone.0028569","article-title":"In\u00a0vivo MRI characterization of progressive cardiac dysfunction in the mdx mouse model of muscular dystrophy","volume":"7","author":"Stuckey","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtm.2019.11.015_bib22","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/mt.2008.28","article-title":"Systemic microdystrophin gene delivery improves skeletal muscle structure and function in old dystrophic mdx mice","volume":"16","author":"Gregorevic","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2019.11.015_bib23","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1038\/mt.2011.154","article-title":"AAV-microdystrophin therapy improves cardiac performance in aged female mdx mice","volume":"19","author":"Bostick","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2019.11.015_bib24","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.yjmcc.2012.05.002","article-title":"AAV micro-dystrophin gene therapy alleviates stress-induced cardiac death but not myocardial fibrosis in >21-m-old mdx mice, an end-stage model of Duchenne muscular dystrophy cardiomyopathy","volume":"53","author":"Bostick","year":"2012","journal-title":"J.\u00a0Mol. Cell. Cardiol."},{"key":"10.1016\/j.omtm.2019.11.015_bib25","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/mt.2008.264","article-title":"Cardiac expression of a mini-dystrophin that normalizes skeletal muscle force only partially restores heart function in aged Mdx mice","volume":"17","author":"Bostick","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2019.11.015_bib26","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/HJR.0b013e3281eacef1","article-title":"Running speed and maximal oxygen uptake in rats and mice: practical implications for exercise training","volume":"14","author":"Hoydal","year":"2007","journal-title":"Eur. J. Cardiovasc. Prev. Rehabil"},{"key":"10.1016\/j.omtm.2019.11.015_bib27","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1152\/japplphysiol.00594.2011","article-title":"High intensity interval training alters substrate utilization and reduces oxygen consumption in the heart","volume":"111","author":"Hafstad","year":"2011","journal-title":"J.\u00a0Appl. Physiol."},{"key":"10.1016\/j.omtm.2019.11.015_bib28","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1152\/japplphysiol.00287.2017","article-title":"Sexually dimorphic skeletal muscle and cardiac dysfunction in a mouse model of limb girdle muscular dystrophy 2i","volume":"123","author":"Maricelli","year":"2017","journal-title":"J.\u00a0Appl. Physiol. (1985)"},{"key":"10.1016\/j.omtm.2019.11.015_bib29","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1152\/japplphysiol.90985.2008","article-title":"Multiple pathological events in exercised dystrophic mdx mice are targeted by pentoxifylline: outcome of a large array of in\u00a0vivo and ex\u00a0vivo tests","volume":"106","author":"Burdi","year":"2009","journal-title":"J.\u00a0Appl. Physiol."},{"key":"10.1016\/j.omtm.2019.11.015_bib30","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.nbd.2008.07.009","article-title":"Gentamicin treatment in exercised mdx mice: Identification of dystrophin-sensitive pathways and evaluation of efficacy in work-loaded dystrophic muscle","volume":"32","author":"De Luca","year":"2008","journal-title":"Neurobiol. Dis."},{"issue":"Suppl 1","key":"10.1016\/j.omtm.2019.11.015_bib31","doi-asserted-by":"crossref","first-page":"S142","DOI":"10.1016\/S0960-8966(02)00100-1","article-title":"Pre-clinical trials in Duchenne dystrophy: what animal models can tell us about potential drug effectiveness","volume":"12","author":"De Luca","year":"2002","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.omtm.2019.11.015_bib32","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.nmd.2009.05.003","article-title":"Developing standard procedures for murine and canine efficacy studies of DMD therapeutics: report of two expert workshops on \u201cPre-clinical testing for Duchenne dystrophy\u201d: Washington DC, October 27th-28th 2007 and Z\u00fcrich, June 30th-July 1st 2008","volume":"19","author":"Nagaraju","year":"2009","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.omtm.2019.11.015_bib33","series-title":"Use of Respiratory and Exercise Performance to Quantify Systemic Muscle Function in mdx Mice","author":"Rodgers","year":"2014"},{"key":"10.1016\/j.omtm.2019.11.015_bib34","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/mus.21211","article-title":"Preclinical drug trials in the mdx mouse: assessment of reliable and sensitive outcome measures","volume":"39","author":"Spurney","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.omtm.2019.11.015_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2008.03.008","article-title":"Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy","volume":"31","author":"Grounds","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.omtm.2019.11.015_bib36","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1089\/hum.2008.058","article-title":"Adeno-associated virus serotype-9 microdystrophin gene therapy ameliorates electrocardiographic abnormalities in mdx mice","volume":"19","author":"Bostick","year":"2008","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2019.11.015_bib37","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1089\/hum.2017.144","article-title":"Cardiac-specific expression of \u0394H2-R15\u00a0mini-dystrophin normalized all electrocardiogram abnormalities and the end-diastolic volume in a 23-month-old mouse model of Duchenne dilated cardiomyopathy","volume":"29","author":"Wasala","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2019.11.015_bib38","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ymthe.2005.04.001","article-title":"Phenotypic improvement of dystrophic muscles by rAAV\/microdystrophin vectors is augmented by Igf1 codelivery","volume":"12","author":"Abmayr","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2019.11.015_bib39","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/S0002-9440(10)64502-6","article-title":"Improved contractile function of the mdx dystrophic mouse diaphragm muscle after insulin-like growth factor-I administration","volume":"161","author":"Gregorevic","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omtm.2019.11.015_bib40","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.1093\/hmg\/ddt342","article-title":"Micro-dystrophin and follistatin co-delivery restores muscle function in aged DMD model","volume":"22","author":"Rodino-Klapac","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2019.11.015_bib41","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/mt.2014.200","article-title":"A phase 1\/2a follistatin gene therapy trial for becker muscular dystrophy","volume":"23","author":"Mendell","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2019.11.015_bib42","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1210\/en.2008-0259","article-title":"Differential antagonism of activin, myostatin and growth and differentiation factor 11 by wild-type and mutant follistatin","volume":"149","author":"Schneyer","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.omtm.2019.11.015_bib43","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3727\/096368908784153913","article-title":"Inhibiting myostatin with follistatin improves the success of myoblast transplantation in dystrophic mice","volume":"17","author":"Benabdallah","year":"2008","journal-title":"Cell Transplant."},{"key":"10.1016\/j.omtm.2019.11.015_bib44","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1097\/01.TP.0000167379.27872.2B","article-title":"Improved success of myoblast transplantation in mdx mice by blocking the myostatin signal","volume":"79","author":"Benabdallah","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.omtm.2019.11.015_bib45","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.archoralbio.2005.09.006","article-title":"Alterations of temporalis muscle contractile force and histological content from the myostatin and Mdx deficient mouse","volume":"51","author":"Byron","year":"2006","journal-title":"Arch. Oral Biol."},{"key":"10.1016\/j.omtm.2019.11.015_bib46","doi-asserted-by":"crossref","first-page":"E41","DOI":"10.1152\/ajpendo.00389.2012","article-title":"Muscle protein synthesis, mTORC1\/MAPK\/Hippo signaling, and capillary density are altered by blocking of myostatin and activins","volume":"304","author":"Hulmi","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.omtm.2019.11.015_bib47","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/mus.21743","article-title":"Activin IIB receptor blockade attenuates dystrophic pathology in a mouse model of Duchenne muscular dystrophy","volume":"42","author":"Morine","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.omtm.2019.11.015_bib48","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/ana.10385","article-title":"Loss of myostatin attenuates severity of muscular dystrophy in mdx mice","volume":"52","author":"Wagner","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtm.2019.11.015_bib50","series-title":"Drugs aim to help elderly rebuild muscle. Wall Street Journal, April 27, 2014","author":"Plumridge","year":"2014"},{"key":"10.1016\/j.omtm.2019.11.015_bib51","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/nbt.3557","article-title":"No longer going to waste","volume":"34","author":"Garber","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtm.2019.11.015_bib52","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1089\/hum.2017.158","article-title":"Systemic Smad7 gene therapy increases striated muscle mass and enhances exercise capacity in a dose-dependent manner","volume":"29","author":"Maricelli","year":"2018","journal-title":"Hum. Gene Ther"},{"key":"10.1016\/j.omtm.2019.11.015_bib53","doi-asserted-by":"crossref","first-page":"348ra98","DOI":"10.1126\/scitranslmed.aac4976","article-title":"Smad7 gene delivery prevents muscle wasting associated with cancer cachexia in mice","volume":"8","author":"Winbanks","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2019.11.015_bib54","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.omtm.2017.06.006","article-title":"A five-repeat micro-dystrophin gene ameliorated dystrophic phenotype in the severe DBA\/2J-mdx model of Duchenne muscular dystrophy","volume":"6","author":"Hakim","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2019.11.015_bib55","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0887-8994(93)90080-V","article-title":"End of life care in Duchenne muscular dystrophy","volume":"9","author":"Hilton","year":"1993","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.omtm.2019.11.015_bib56","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.ejpn.2016.07.020","article-title":"Why are some patients with Duchenne muscular dystrophy dying young: an analysis of causes of death in North East England","volume":"20","author":"Van Ruiten","year":"2016","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.omtm.2019.11.015_bib57","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/00005768-200001000-00012","article-title":"Limiting factors for maximum oxygen uptake and determinants of endurance performance","volume":"32","author":"Bassett","year":"2000","journal-title":"Med. Sci. Sports Exerc."},{"key":"10.1016\/j.omtm.2019.11.015_bib58","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jpeds.2009.02.007","article-title":"Delayed diagnosis in Duchenne muscular dystrophy: data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet)","volume":"155","author":"Ciafaloni","year":"2009","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.omtm.2019.11.015_bib59","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1053\/ejpn.2000.0309","article-title":"Delayed diagnosis of Duchenne muscular dystrophy","volume":"4","author":"Mohamed","year":"2000","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.omtm.2019.11.015_bib60","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1038\/ejhg.2014.301","article-title":"A mixed methods study of age at diagnosis and diagnostic odyssey for Duchenne muscular dystrophy","volume":"23","author":"Wong","year":"2015","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.omtm.2019.11.015_bib61","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/sj.mt.6300027","article-title":"Design of tissue-specific regulatory cassettes for high-level rAAV-mediated expression in skeletal and cardiac muscle","volume":"15","author":"Salva","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2019.11.015_bib62","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-61737-982-6_1","article-title":"Design and testing of regulatory cassettes for optimal activity in skeletal and cardiac muscles","volume":"709","author":"Himeda","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omtm.2019.11.015_bib63","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/mt.2010.308","article-title":"Transcription factor rational design improves directed differentiation of human mesenchymal stem cells into skeletal myocytes","volume":"19","author":"Gon\u00e7alves","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2019.11.015_bib64","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1089\/hum.2008.197","article-title":"Partial rescue of growth failure in growth hormone (GH)-deficient mice by a single injection of a double-stranded adeno-associated viral vector expressing the GH gene driven by a muscle-specific regulatory cassette","volume":"20","author":"Martari","year":"2009","journal-title":"Hum. Gene Ther."},{"issue":"R1","key":"10.1016\/j.omtm.2019.11.015_bib65","doi-asserted-by":"crossref","first-page":"R9","DOI":"10.1093\/hmg\/ddv420","article-title":"Progress and prospects of gene therapy clinical trials for the muscular dystrophies","volume":"25","author":"Bengtsson","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2019.11.015_bib66","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1038\/mt.2014.99","article-title":"Myocyte-mediated arginase expression controls hyperargininemia but not hyperammonemia in arginase-deficient mice","volume":"22","author":"Hu","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2019.11.015_bib67","doi-asserted-by":"crossref","first-page":"14025","DOI":"10.1038\/mtm.2014.25","article-title":"Engraftment potential of dermal fibroblasts following in\u00a0vivo myogenic conversion in immunocompetent dystrophic skeletal muscle","volume":"1","author":"Muir","year":"2014","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2019.11.015_bib68","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.bbapap.2010.05.001","article-title":"Dystrophin: more than just the sum of its parts","volume":"1804","author":"Le Rumeur","year":"2010","journal-title":"Biochim. Biophys. Acta"}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050119301408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050119301408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:25:06Z","timestamp":1762421106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050119301408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":67,"alternative-id":["S2329050119301408"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2019.11.015","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Micro-dystrophin Gene Therapy Partially Enhances Exercise Capacity in Older Adult mdx Mice","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2019.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors.","name":"copyright","label":"Copyright"}]}}